Cargando…
Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction
Synthetic lethality is a successful strategy employed to develop selective chemotherapeutics against cancer cells. Inactivation of RAD52 is synthetically lethal to homologous recombination (HR) deficient cancer cell lines. Replication protein A (RPA) recruits RAD52 to repair sites, and the formation...
Autores principales: | Al-Mugotir, Mona, Lovelace, Jeffrey J., George, Joseph, Bessho, Mika, Pal, Dhananjaya, Struble, Lucas, Kolar, Carol, Rana, Sandeep, Natarajan, Amarnath, Bessho, Tadayoshi, Borgstahl, Gloria E. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009417/ https://www.ncbi.nlm.nih.gov/pubmed/33784323 http://dx.doi.org/10.1371/journal.pone.0248941 |
Ejemplares similares
-
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
por: Rauth, Sanchita, et al.
Publicado: (2023) -
Protein phosphatase 1 and phosphatase 1 nuclear targeting subunit-dependent regulation of DNA-dependent protein kinase and non-homologous end joining
por: Zhu, Songli, et al.
Publicado: (2017) -
Human Replication Protein A−Rad52−Single-Stranded DNA Complex: Stoichiometry and Evidence for Strand Transfer Regulation by Phosphorylation
por: Deng, Xiaoyi, et al.
Publicado: (2009) -
Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine
por: George, Joseph W., et al.
Publicado: (2019) -
Homodecameric Rad52 promotes single-position Rad51 nucleation in homologous recombination
por: Deveryshetty, Jaigeeth, et al.
Publicado: (2023)